These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10589959

  • 1. Pentosan polysulfate treatment reduces cyclosporine-induced nephropathy in salt-depleted rats.
    Schwedler SB, Bobadilla N, Striker LJ, Vaamonde CA, Herrera-Acosta J, Striker GE.
    Transplantation; 1999 Nov 27; 68(10):1583-8. PubMed ID: 10589959
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.
    Vieira JM, Noronha IL, Malheiros DM, Burdmann EA.
    Transplantation; 1999 Dec 15; 68(11):1746-53. PubMed ID: 10609952
    [Abstract] [Full Text] [Related]

  • 3. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
    Shihab FS, Yi H, Bennett WM, Andoh TF.
    Kidney Int; 2000 Sep 15; 58(3):1174-85. PubMed ID: 10972680
    [Abstract] [Full Text] [Related]

  • 4. Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity.
    Yuan J, Zhou J, Chen BC, Zhang X, Zhou HM, Du DF, Chang S, Chen ZK.
    Transplant Proc; 2005 May 15; 37(4):1892-5. PubMed ID: 15919495
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nifedipine prevents changes in nitric oxide synthase mRNA levels induced by cyclosporine.
    Sánchez-Lozada LG, Gamba G, Bolio A, Jiménez F, Herrera-Acosta J, Bobadilla NA.
    Hypertension; 2000 Oct 15; 36(4):642-7. PubMed ID: 11040251
    [Abstract] [Full Text] [Related]

  • 7. Hyperuricemia exacerbates chronic cyclosporine nephropathy.
    Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA, Hughes J, Kivlighn SD, Lan HY, Johnson RJ.
    Transplantation; 2001 Apr 15; 71(7):900-5. PubMed ID: 11349724
    [Abstract] [Full Text] [Related]

  • 8. Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition.
    Gardner MP, Houghton DC, Andoh TF, Lindsley J, Bennett WM.
    Transplantation; 1996 May 27; 61(10):1506-12. PubMed ID: 8633380
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy.
    Young BA, Burdmann EA, Johnson RJ, Andoh T, Bennett WM, Couser WG, Alpers CE.
    Kidney Int; 1995 Aug 27; 48(2):431-8. PubMed ID: 7564110
    [Abstract] [Full Text] [Related]

  • 10. Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy.
    Li C, Yang CW, Park JH, Lim SW, Sun BK, Jung JY, Kim SB, Kim YS, Kim J, Bang BK.
    Am J Physiol Renal Physiol; 2004 Jan 27; 286(1):F46-57. PubMed ID: 14519596
    [Abstract] [Full Text] [Related]

  • 11. Role of NO in cyclosporin nephrotoxicity: effects of chronic NO inhibition and NO synthases gene expression.
    Bobadilla NA, Gamba G, Tapia E, García-Torres R, Bolio A, López-Zetina P, Herrera-Acosta J.
    Am J Physiol; 1998 Apr 27; 274(4):F791-8. PubMed ID: 9575905
    [Abstract] [Full Text] [Related]

  • 12. Isoform-specific regulation of nitric oxide synthase mRNA in the kidney by sodium and blood pressure.
    Nadaud S, Mao C, Luvàra G, Michel JB, Soubrier F.
    J Hypertens; 1998 Sep 27; 16(9):1315-23. PubMed ID: 9746119
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation.
    Ling H, Li X, Jha S, Wang W, Karetskaya L, Pratt B, Ledbetter S.
    J Am Soc Nephrol; 2003 Feb 27; 14(2):377-88. PubMed ID: 12538738
    [Abstract] [Full Text] [Related]

  • 14. Does methylene blue protect the kidney tissues from damage induced by ciclosporin A treatment?
    Rezzani R, Rodella L, Corsetti G, Bianchi R.
    Nephron; 2001 Nov 27; 89(3):329-36. PubMed ID: 11598398
    [Abstract] [Full Text] [Related]

  • 15. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
    Sun BK, Li C, Lim SW, Jung JY, Lee SH, Kim IS, Kim YS, Kim J, Bang BK, Yang CW.
    J Lab Clin Med; 2004 Mar 27; 143(3):175-83. PubMed ID: 15007308
    [Abstract] [Full Text] [Related]

  • 16. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M, Santisteban J, Finckenberg P, Salmenperä P, Riutta A, Moilanen E, Virtanen I, Vapaatalo H, Nurminen ML.
    J Physiol Pharmacol; 2001 Mar 27; 52(1):21-38. PubMed ID: 11321510
    [Abstract] [Full Text] [Related]

  • 17. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M, Burke JF, McGowan TA, Zhu Y, Dunn SR, McCue P, Kanalas J, Sharma K.
    Kidney Int; 2001 Feb 27; 59(2):498-506. PubMed ID: 11168932
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive rats.
    Guan Z, Singletary ST, Cha H, Van Beusecum JP, Cook AK, Pollock JS, Pollock DM, Inscho EW.
    Am J Physiol Renal Physiol; 2016 Mar 15; 310(6):F456-65. PubMed ID: 26697978
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.